Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
42.48
-0.50 (-1.16%)
Apr 29, 2026, 12:53 PM EDT - Market open
Enliven Therapeutics Market Cap
Enliven Therapeutics has a market cap or net worth of $2.54 billion as of April 29, 2026. Its market cap has increased by 213.98% in one year.
Market Cap
2.54B
Enterprise Value
2.11B
1-Year Change
213.98%
Ranking
Category
Stock Price
$42.48
Market Cap Chart
Since February 24, 2023, Enliven Therapeutics's market cap has increased from $974.02M to $2.54B, an increase of 160.81%. That is a compound annual growth rate of 35.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 2.57B | 181.22% |
| Dec 31, 2025 | 913.95M | -16.86% |
| Dec 31, 2024 | 1.10B | 92.74% |
| Dec 29, 2023 | 570.37M | -41.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Soleno Therapeutics | 2.73B |
| Beam Therapeutics | 2.72B |
| Vera Therapeutics | 2.70B |
| IDEAYA Biosciences | 2.70B |
| Immunome | 2.67B |
| Disc Medicine | 2.63B |
| ADMA Biologics | 2.62B |
| Tarsus Pharmaceuticals | 2.62B |